Skip to main contentAll experts

DrGlen Doherty

Clinical Full Professor

School of Medicine

Orcid identifier0000-0003-4384-5049 (opens in a new tab)⁠
  • Clinical Full Professor
    School of Medicine
  • (01)2214711
  • University College Dublin, School of Medicine, St Vincent's Hospital Elm Park Dublin 4

RESEARCH INTERESTS

Glen's research interests are in the role of innate and adaptive immunity in inflammatory bowel disease (Ulcerative Colitis and Crohn's Disease) and in the importance of the host immune response in gastro-intestinal neoplasia, particularly Colorectal Cancer/Neoplasia. He has an established track record in clinical and translational research on a range of digestive disorders and is actively involved in clinical trials in IBD. He has supervised multiple research Masters and MD students over the last 15 years.

GRANTS

  • PROJECT GRANT
    Understanding and Enhancing Early Recognition of Community-Onset Sepsis in General Practice: A Feasibility Randomised Controlled Trial
    University College Dublin (UCD)2 Nov 2026 - 1 Nov 2027
    People funded by this grant:
  • PROGRAMME
    Analytic Understanding of Gut Microenvironment to Enhance New Treatments (AUGMENT) Rational integration of precision nutrition, microbiome and immune response to optimise immunotherapy in IBD and other inflammatory diseases
    Science Foundation Ireland (SFI)1 Jan 2024 - 31 Aug 2026
    People funded by this grant:
    • Doherty G
  • GRANT
    Serological response rates to the COVID-19 vaccination in patients with Inflammatory Bowel Disease.
    Abbott Laboratories10 Dec 2021 - 9 Dec 2022
    People funded by this grant:
    • Doherty G,
    • Doran P
  • GRANT
    Validation and commercial development of 'CASPDx' - a blood-based colorectal cancer screening test
    Enterprise Ireland (EI)1 Sep 2021 - 31 Mar 2025
    People funded by this grant:
    • Doherty G
  • GRANT
    UCD Foundation support for a TopMed 10 fellow
    University College Dublin Foundation Clg24 Nov 2016 - 23 Nov 2019
    People funded by this grant:
    • Doherty G
  • GRANT
    Golimumab (GLM) dose Optimisation to Adequate Levels to Achieve Response in Colitis (GOAL-ARC)
    Merck Sharp & Dohme (Ireland)11 Nov 2015 - 31 Mar 2023
    People funded by this grant:
    • Doherty G
  • GRANT
    GREEN LIGHT: Assessment of the diagnostic commercial potential of a breath ammonia measurement system - giving AmBeR® the green light
    Enterprise Ireland (EI)1 Oct 2015 - 31 Aug 2016
    People funded by this grant:
    • Doherty G
  • GRANT
    Research Activities
    University College Dublin Foundation Clg5 Jan 2015 - 4 Jan 2016
    People funded by this grant:
    • Doherty G